Twirla - A New Contraceptive Patch

Date: February 8, 2021 Issue #:  1617Summary:  The FDA has approvedTwirla (Agile Therapeutics), a transdermal contraceptive patch containing the estrogen ethinyl estradiol and the progestin levonorgestrel, for use in women with a BMI<30 kg/m2. It is the second contraceptive patch to become available in the US;Xulane, a patch that delivers ethinyl estradiol and the progestin norelgestromin, has been available since 2014.
Source: The Medical Letter - Category: Drugs & Pharmacology Authors: Tags: Contraceptives Estrogens Evra IUD Levonorgestrel Nexplanon ombitasvir Oral contraceptives paritaprevir Progestins Ritonavir Technivie Twirla Viekira Pak Xulane Source Type: research